1. Search Result
Search Result
Results for "

FRa

" in MedChemExpress (MCE) Product Catalog:

10

Inhibitors & Agonists

3

Inhibitory Antibodies

8

Antibodies

4

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-P99612

    MORAb-202

    Antibody-Drug Conjugates (ADCs) Cancer
    Farletuzumab ecteribulin (MORAb-202) is an antibody-drug conjugate (ADC), consisting of the humanized anti-human folate receptor alpha (FRA) antibody Farletuzumab (HY-P99153) conjugated via reduced interchain disulfide bonds to Mal-PEG2-Val-Cit-PAB-eribulin. Farletuzumab ecteribulin has a agent-to-antibody ratio of 4.0. Farletuzumab ecteribulin is highly cytotoxic to FRA-positive cells in vitro. Farletuzumab ecteribulin has potent antitumor activity.
    Farletuzumab ecteribulin
  • HY-17663

    PARP STAT STING IFNAR Cancer
    KMR-206 is a PARP7 inhibitor with an IC50 of 13.7 nM. KMR-206 relieves AHR-mediated transcriptional repression and enhances CYP1A1 expression in the presence of TCDD. KMR-206 induces the STING-dependent IFN-β signaling pathway and increases the levels of STAT1, pSTAT1 and nuclear PARP7 in cancer cells. KMR-206 reduces the viability of lung adenocarcinoma cells, enhances radiation-induced immunogenic signals, and induces the production of immunogenic signals in glioblastoma cancer stem cells. KMR-206 destabilizes FRA1 to increase IRF1 levels and promotes the IRF3-CBP/p300 interaction. KMR-206 can be used in studies related to lung adenocarcinoma and glioblastoma .
    KMR-206
  • HY-RS05034

    Small Interfering RNA (siRNA) Others

    FOSL1 Human Pre-designed siRNA Set A contains three designed siRNAs for FOSL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    FOSL1 Human Pre-designed siRNA Set A
    FOSL1 Human Pre-designed siRNA Set A
  • HY-P990417

    Antifolate Inflammation/Immunology
    Anti-FOLR1/FRA Antibody is a humanized antibody expressed in CHO cells, targeting FOLR1/FRA. The Anti-FOLR1/FRA Antibody contains a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 146.46 kDa. The isotype control for the Anti-FOLR1/FRA Antibody can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).
    Anti-FOLR1/FRA Antibody
  • HY-RS05088

    Small Interfering RNA (siRNA) Others

    FRA10AC1 Human Pre-designed siRNA Set A contains three designed siRNAs for FRA10AC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    FRA10AC1 Human Pre-designed siRNA Set A
    FRA10AC1 Human Pre-designed siRNA Set A
  • HY-123728

    Histamine Receptor Inflammation/Immunology
    FR-A-19 is a potent histamine H2-agonist with IC50 values of 0.02, 0.015, and 0.008 μM targets arpromidine, BUA-75, and FRA-19 respectively. FR-A-19 has potent anti-allergic properties .
    FR-A-19
  • HY-RS05089

    Small Interfering RNA (siRNA) Others

    FRAS1 Human Pre-designed siRNA Set A contains three designed siRNAs for FRAS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    FRAS1 Human Pre-designed siRNA Set A
    FRAS1 Human Pre-designed siRNA Set A
  • HY-RS11583

    Small Interfering RNA (siRNA) Others

    RABEP2 Human Pre-designed siRNA Set A contains three designed siRNAs for RABEP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    RABEP2 Human Pre-designed siRNA Set A
    RABEP2 Human Pre-designed siRNA Set A
  • HY-P992003

    IKS01 Antibody

    ADC Antibody Cancer
    IKS012 (IKS01) Antibody is a monoclonal antibody inhibitor targeting folate receptor α (FRA). IKS012 Antibody can be used to synthesize the antibody-drug conjugate (ADC) IKS012. IKS012 Antibody can be used to research related to platinum-resistant ovarian cancer .
    IKS012 Antibody
  • HY-P992515

    ADC Antibody Folate Receptor (FR) Cancer
    ZW-191 Antibody is a humanized IgG1 antibody targeting folate receptor α (FRα). ZW-191 Antibody is conjugated with MC-GGFG-AM-(10Me-11F-Camptothecin) (HY-153360) to generate the antibody-drug conjugate (ADC) ZW-191 (HY-185743). ZW-191 Antibody-based ADC exerts a potent bystander effect on both antigen-positive and antigen-negative cells. ZW-191 Antibody is applicable to research related to ovarian cancer, non-small cell lung cancer, endometrial cancer, and triple-negative breast cancer .
    ZW-191 Antibody

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: